Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.31B P/E 1,796.40 EPS this Y 34.90% Ern Qtrly Grth 1,298.50%
Income 90.95M Forward P/E 96.24 EPS next Y 36.20% 50D Avg Chg -16.00%
Sales 1.06B PEG 0.40 EPS past 5Y 1.53% 200D Avg Chg 3.00%
Dividend N/A Price/Book 9.70 EPS next 5Y 188.35% 52W High Chg -23.00%
Recommedations 2.00 Quick Ratio 3.25 Shares Outstanding 38.70M 52W Low Chg 94.00%
Insider Own 3.82% ROA 3.92% Shares Float 37.19M Beta 0.53
Inst Own 89.81% ROE 8.35% Shares Shorted/Prior 1.93M/1.97M Price 269.46
Gross Margin 64.49% Profit Margin 8.59% Avg. Volume 373,338 Target Price 277.38
Oper. Margin 12.31% Earnings Date May 7 Volume 1,608,294 Change -9.68%
About Penumbra, Inc.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Penumbra, Inc. News
04/09/24 Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
04/08/24 Here's Why You Should Retain Penumbra (PEN) Stock for Now
04/04/24 Insider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
12:38 PM Are Penumbra, Inc.'s (NYSE:PEN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
03/05/24 Penumbra (PEN) Gains From Innovation, Mounting Costs Ail
02/26/24 Penumbra (PEN) Q4 Earnings Top Estimates, Margins Increase
02/24/24 Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
02/23/24 Q4 2023 Penumbra Inc Earnings Call
02/23/24 Penumbra, Inc. (NYSE:PEN) Q4 2023 Earnings Call Transcript
02/23/24 Decoding Penumbra Inc (PEN): A Strategic SWOT Insight
02/22/24 Penumbra (PEN) Q4 Earnings Beat Estimates
02/22/24 Penumbra Inc (PEN) Reports Robust Revenue Growth and Profitability in Q4 and Full Year 2023
02/22/24 Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
02/18/24 25 Most Valuable Medical Device Companies in the US
02/15/24 Penumbra (PEN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
02/01/24 Penumbra, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 22, 2024
02/01/24 Here's What's Concerning About Penumbra's (NYSE:PEN) Returns On Capital
01/18/24 Penumbra (PEN) Rides on Vascular Arm Strength Amid FX Woes
01/11/24 Estimating The Intrinsic Value Of Penumbra, Inc. (NYSE:PEN)
12/29/23 5 Impressive MedTech Industry Growth Stocks to Buy for 2024
PEN Chatroom

User Image Stock_Titan Posted - 1 week ago

$PEN Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 https://www.stocktitan.net/news/PEN/penumbra-inc-schedules-first-quarter-2024-earnings-release-and-bf6c1c3ph8tf.html

User Image Looking4Bargain Posted - 2 weeks ago

$NARI weird thing is that $PEN is on same trend. Where is market share shifting out to. In any case this is good entry point for this stock

User Image Looking4Bargain Posted - 2 weeks ago

$PEN I had bought this at $136 levels and sold it out $324. My personal best in gains of all time. I think that time is coming again to rock this out and buy bulk at wholesale. I had gone to their booth at TCT 23' and it was always busy. Just need to get my price.

User Image CoreGizmo Posted - 2 weeks ago

@DonCorleone77 what are your thoughts on $PEN. Decent quarter but continues to drop. Mentioned as a potential buyer of $SWAV. Analyst target around $280. Thoughts on why it keeps dropping?

User Image Nurse007 Posted - 2 weeks ago

$PEN thinking of buying more soon.

User Image Nurse007 Posted - 1 month ago

$PEN back in

User Image WallStJesus Posted - 1 month ago

$PEN UNUSUAL DEC BULL SWEEPER DETECTED

User Image insiderbuyingselling Posted - 1 month ago

$PEN new insider selling: 7500 shares. http://insiderbuyingselling.com/?t=PEN

User Image Hpad06 Posted - 1 month ago

$NARI vs $pen , why pen is holding up so well and nari keeps going lower?

User Image StockInvest_us Posted - 1 month ago

Signal alert: $PEN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/Y7htuMR2KG

User Image StockInvest_us Posted - 02/28/24

Signal alert: $PEN - Oversold Trend Short (Undervalued) https://stockinvest.us/l/tX2tc7i51l

User Image TickerDD_com Posted - 02/26/24

From 2/22/2024, looking back across 22 Month-Ends for PEN, Percentage Change of Average Monthly Price had More Positives (73%) while Percentage Change of Average Monthly Volume had All Positives (100%) $PEN #PEN #PENStock #TickerDD #PENPrice https://www.youtube.com/watch?v=rnEF6lSNtSQ

User Image Thestocktraderhubzee Posted - 02/26/24

WATCHLIST FEB 26 2024. $RCEL Cantor Fitzgerald Maintains Overweight on AVITA Medical, Raises Price Target to $25 $LUNR Cantor Fitzgerald Maintains Overweight on Intuitive Machines, Raises Price Target to $13 $PEN RBC Capital Reiterates Outperform on Penumbra, Maintains $289 Price Target $RIVN Rivian shares are trading lower after UBS downgraded the stock from Buy to Sell and lowered its price target from $24 to $8. $MRNA RBC Capital Reiterates Outperform on Moderna, Maintains $125 Price Target

User Image Nurse007 Posted - 02/23/24

$PEN back in

User Image stockpicker63 Posted - 02/23/24

$WBD $FOXF $PEN $GH $WBD now +3.9% and $FOXF +3%

User Image stockpicker63 Posted - 02/23/24

NICE stock to buy and make profit! $PEN, $WBD, $FOXF, $GH .

User Image Thestocktraderhubzee Posted - 02/23/24

$PEN Canaccord Genuity Reiterates Buy on Penumbra, Maintains $284 Price Target

User Image Estimize Posted - 02/22/24

$PEN beats the Estimize EPS Consensus by 9c and misses the Estimize Revenue Consensus by $4.91M. Reports FQ4 earnings of 76c EPS and $2... http://www.estimize.com/pen/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 02/22/24

$PEN Penumbra sees FY24 revenue $1.23B-$1.27B, consensus $1.27B Representing year over year growth of 16% to 20% compared to 2023 revenue of $1,058.5 million. The company also projects the U.S. thrombectomy franchise will grow 27% to 30% year-over-year, primarily driven by its Computer-Assisted Vacuum Thrombectomy products. The company also expects gross margin expansion in the range of 100 to 150 basis points and total non-GAAP operating margin expansion in the range of 100 to 200 basis points in 2024 compared to full year 2023.

User Image epsguid Posted - 02/22/24

$PEN reported earnings of $0.76, consensus was $0.71, Earnings Whisper was $0.82 via @eWhispers #whispermiss http://eps.sh/d/pen

User Image Stock_Titan Posted - 02/22/24

$PEN Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/PEN/penumbra-inc-reports-fourth-quarter-and-full-year-2023-financial-5a8wch7nrrce.html

User Image StreetwiseReports Posted - 02/22/24

Discovery Potential 50-100% Greater With This Energy Co.: https://ow.ly/l7g050QGPcT Panoro Energy ASA's Hibiscus South well has the potential to be 50-100% larger than expected, according to an Auctus Advisors research note. $PEN:OSE #energy #oil #oilstocks

User Image Estimize Posted - 02/22/24

$PEN reports after the close, Estimize Consensus -0.03 EPS and +2.97M Revs compared to WS http://www.estimize.com/pen/fq4-2023?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image kapakas Posted - 02/22/24

$PEN soooo positive er?

User Image Iknownothing777 Posted - 02/21/24

Is $PEN CEO an Idiot? https://www.benzinga.com/general/sports-betting/24/02/37239149/exclusive-draftkings-partnership-with-barstool-sports-getting-the-band-together-ceo-says-h?utm_campaign=partner_feed&utm_source=MarketWatch&utm_medium=partner_feed&utm_content=site&mod=mw_quote_news

User Image swingingtech Posted - 02/20/24

$PEN https://wallstreetwaves.com/heres-why-you-should-retain-penumbra-pen-stock-for-now/

User Image Doozio Posted - 2 months ago

$PEN so da huckleberries arrive next week FOUR it’s 1st 🧠⏰ eps?

User Image StreetwiseReports Posted - 2 months ago

Safety Move Impacts Energy Co.'s Operations in EG: https://ow.ly/eR3k50QzQyZ While Panoro Energy's rig in Equatorial Guinea was terminated, the financial impact should be minimal, noted an Auctus Advisors report. $PEN:OSE #energy #oil #stocks

User Image History101 Posted - 2 months ago

$PEN 848 watching 2/7/2024

User Image Bizbound Posted - 01/29/24

$NARI this board is dead even on a strong green candle! Well looking good at least. Let’s go! $72 $PEN $PFE $MRNA

Analyst Ratings
Piper Sandler Overweight Apr 3, 24
Truist Securities Buy Mar 22, 24
Piper Sandler Overweight Feb 23, 24
RBC Capital Outperform Feb 23, 24
Canaccord Genuity Buy Feb 23, 24
Truist Securities Buy Feb 23, 24
JP Morgan Neutral Feb 23, 24
RBC Capital Outperform Jan 12, 24
RBC Capital Outperform Jan 11, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Sarna Surbhi Director Director Jan 02 Sell 247.68 85 21,053 2,295 01/04/24
Grewal Harpreet Director Director Jan 03 Sell 240.82 170 40,939 8,980 01/04/24
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Dec 27 Option 22.04 2,450 53,998 63,597 12/29/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Dec 01 Sell 225.41 600 135,246 62,251 12/05/23
O'Rourke Bridget Director Director Nov 30 Sell 226.41 150 33,962 4,214 12/04/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Nov 14 Sell 213.82 600 128,292 63,037 11/16/23
Elsesser Adam CEO and President CEO and President Oct 11 Sell 220.96 9,670 2,136,683 10/13/23
Elsesser Adam CEO and President CEO and President Oct 11 Option 7.75 9,670 74,942 9,670 10/13/23
Shiu Lambert Chief Accounting Off.. Chief Accounting Officer Oct 09 Option 12.36 2,750 33,990 19,466 10/11/23
Grewal Harpreet Director Director Oct 02 Sell 240.99 170 40,968 9,150 10/04/23
Sarna Surbhi Director Director Oct 02 Sell 240.99 85 20,484 2,380 10/04/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Oct 02 Sell 238.59 600 143,154 63,637 10/04/23
Elsesser Adam CEO and President CEO and President Sep 11 Sell 298.4 9,666 2,884,334 09/13/23
Elsesser Adam CEO and President CEO and President Sep 11 Option 7.75 9,666 74,912 9,666 09/13/23
Kassing Don W. Director Director Sep 08 Sell 288.66 444 128,165 1,458 09/12/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Sep 01 Sell 265.38 600 159,228 64,237 09/06/23
Grewal Harpreet Director Director Sep 01 Sell 266.62 340 90,651 9,320 09/06/23
Sarna Surbhi Director Director Sep 01 Sell 266.62 85 22,663 2,465 09/06/23
O'Rourke Bridget Director Director Sep 01 Sell 266.62 100 26,662 4,364 09/06/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Aug 14 Sell 249.14 600 149,484 64,837 08/16/23
Elsesser Adam CEO and President CEO and President Aug 11 Sell 247.41 9,666 2,391,465 08/14/23
Elsesser Adam CEO and President CEO and President Aug 11 Option 7.75 9,666 74,912 9,666 08/14/23
Wilder Thomas Director Director Aug 07 Sell 253.48 340 86,183 340 08/09/23
Kassing Don W. Director Director Aug 08 Sell 251 323 81,073 1,902 08/09/23
Elsesser Adam CEO and President CEO and President Jul 11 Option 7.75 9,666 74,912 9,666 07/13/23
Elsesser Adam CEO and President CEO and President Jul 11 Sell 324.24 9,666 3,134,104 07/13/23
Sarna Surbhi Director Director Jul 03 Sell 341.45 27 9,219 2,550 07/06/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Jul 03 Sell 340.63 900 306,567 65,437 07/06/23
Elsesser Adam CEO and President CEO and President Jun 12 Sell 324.26 9,666 3,134,297 06/14/23
Elsesser Adam CEO and President CEO and President Jun 12 Option 7.75 9,666 74,912 9,666 06/14/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Jun 01 Sell 310.2 900 279,180 66,337 06/05/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary May 12 Sell 320.61 1,500 480,915 68,925 05/16/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary May 12 Option 22.04 652 14,370 70,425 05/16/23
Elsesser Adam CEO and President CEO and President May 11 Sell 319.05 9,666 3,083,937 05/15/23
Elsesser Adam CEO and President CEO and President May 11 Option 7.75 9,666 74,912 9,666 05/15/23
Bose Arani Director Director May 01 Sell 286.22 5,000 1,431,100 182,629 05/03/23
Bose Arani Director Director Apr 03 Sell 275.93 5,000 1,379,650 431,342 04/05/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Apr 03 Sell 277.69 600 166,614 69,960 04/05/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Apr 03 Option 22.04 600 13,224 70,560 04/05/23
Sarna Surbhi Director Director Apr 03 Sell 276.37 28 7,738 2,577 04/05/23
Grewal Harpreet Director Director Mar 29 Sell 271 875 237,125 9,660 03/31/23
Grewal Harpreet Director Director Mar 15 Sell 254.98 875 223,108 10,535 03/17/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Mar 01 Sell 258.21 600 154,926 69,960 03/03/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Mar 01 Option 22.04 600 13,224 70,560 03/03/23
Grewal Harpreet Director Director Mar 01 Sell 259.48 710 184,231 11,410 03/03/23
Bose Arani Director Director Mar 01 Sell 258.38 5,000 1,291,900 436,342 03/03/23
Bose Arani Director Director Feb 01 Sell 253.89 5,000 1,269,450 440,662 02/03/23
Roberts Johanna EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secretary Dec 28 Option 22.04 5,750 126,730 69,960 02/03/23
Kassing Don W. Director Director Jan 27 Sell 243.54 693 168,773 1,545 01/31/23
Bose Arani Director Director Jan 23 Sell 250.25 20,000 5,005,000 445,662 01/25/23